scispace - formally typeset
Open AccessJournal ArticleDOI

Genetic variants of IL-13 signalling and human asthma and atopy

TLDR
Detailed molecular modelling analyses indicate that residue 110 of IL-13, the site of the charge-modifying variants Arg and Gln, is important in the internal constitution of the ligand and crucial in ligand-receptor interaction, likely to be important promoters of human asthma.
Abstract
Asthma and atopy show epidemiological association and are biologically linked by T-helper type 2 (T(h)2) cytokine-driven inflammatory mechanisms IL-4 operates through the IL-4 receptor (IL-4R, a heterodimer of IL-4Ralpha and either gammac or IL-13Ralpha1) and IL-13 operates through IL-13R (a heterodimer of IL-4Ralpha and IL-13Ralpha1) to promote IgE synthesis and IgE-based mucosal inflammation which typify atopy Recent animal model data suggest that IL-13 is a central cytokine in promoting asthma, through the stimulation of bronchial epithelial mucus secretion and smooth muscle hyper-reactivity We investigated the role of common genetic variants of IL-13 and IL-13Ralpha1 in human asthma, considering IgE levels A novel variant of human IL-13, Gln110Arg, on chromosome 5q31, associated with asthma rather than IgE levels in case-control populations from Britain and Japan [peak odds ratio (OR) = 231, 95% CI 133-400]; the variant also predicted asthma and higher serum IL-13 levels in a general, Japanese paediatric population Immunohistochemistry demonstrated that both subunits of IL-13R are prominently expressed in bronchial epithelium and smooth muscle from asthmatic subjects Detailed molecular modelling analyses indicate that residue 110 of IL-13, the site of the charge-modifying variants Arg and Gln, is important in the internal constitution of the ligand and crucial in ligand-receptor interaction A non-coding variant of IL-13Ralpha1, A1398G, on chromosome Xq13, associated primarily with high IgE levels (OR = 3 38 in males, 110 in females) rather than asthma Thus, certain variants of IL-13 signalling are likely to be important promoters of human asthma; detailed functional analysis of their actions is needed

read more

Citations
More filters
Journal ArticleDOI

Asthma: Mechanisms of Disease Persistence and Progression

TL;DR: Human and animal data are reviewed detailing the cellular and molecular interactions in established allergic asthma that promote persistent disease, amplify inflammation, and, in turn, cause disease progression.
Journal ArticleDOI

Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury.

TL;DR: Levels of YKL-40 in the lung and serum are increased in asthma and other inflammatory and remodeling disorders and often correlate with disease severity, indicating understanding of the roles of C/CLPs in inflammation, tissue remodeling, and tissue injury in health and disease.
Journal ArticleDOI

Interleukin-13 in asthma pathogenesis

TL;DR: Current understanding of the singular role of IL‐13 in the pathogenesis of asthma is explored, with a particular focus on new insights into the mechanisms by which this cytokine mediates various features of asthma.
Journal ArticleDOI

Discovering susceptibility genes for asthma and allergy

TL;DR: Despite the achievements made in asthma genetics formidable challenges remain, the development of novel, powerful tools for gene discovery, and a closer integration of genetics and biology should help to overcome these challenges.
References
More filters
Journal ArticleDOI

TGF-beta signal transduction.

TL;DR: The transforming growth factor beta (TGF-beta) family of growth factors control the development and homeostasis of most tissues in metazoan organisms and mutations in these pathways are the cause of various forms of human cancer and developmental disorders.
Journal ArticleDOI

Interleukin-13: Central Mediator of Allergic Asthma

TL;DR: In this paper, the type 2 cytokine IL-13, which shares a receptor component and signaling pathways with IL-4, was found to be necessary and sufficient for the expression of allergic asthma.
Journal Article

Interleukin-13: Central mediator of allergic asthma

TL;DR: In this article, the type 2 cytokine IL-13, which shares a receptor component and signaling pathways with IL-4, was found to be necessary and sufficient for the expression of allergic asthma.
Journal ArticleDOI

Human Growth Hormone and Extracellular Domain of Its Receptor: Crystal Structure of the Complex

TL;DR: Examination of the 2.8 angstrom crystal structure of the complex between the hormone and the extracellular domain of its receptor (hGHbp) showed that the complex consists of one molecule of growth hormone per two molecules of receptor.
Journal ArticleDOI

Requirement for IL-13 Independently of IL-4 in Experimental Asthma

TL;DR: This article showed that IL-4 receptor α chain-dependent pathway may underlie the genetic associations of asthma with both the human 5q31 locus and the IL4 receptor and showed that selective neutralization of IL-13, a cytokine related to interleukin-4 that also binds to the α chain of the IL 4 receptor, ameliorated asthma phenotype.
Related Papers (5)